Martine F. Roussel

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

M. Roussel, P. Northcott, J. Liu, 2022, Molecular cancer therapeutics.

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

David T. W. Jones, M. Roussel, M. Kool, 2018, Acta Neuropathologica.

Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition

M. Rees, S. Nance, Sarah Robinson, 2024, Nature communications.

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

P. Northcott, G. Robinson, A. Onar-Thomas, 2022, Molecular cancer therapeutics.

Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma

R. Bindra, Erika Belitzky, Minsoo Khang, 2023, Science Translational Medicine.